Lexaria: oral GLP-1 drugs could reach $89 billion market by 2034
Lexaria cited Grandview Research data showing the oral GLP-1 market could reach $89 billion by 2034, from about $5.1 billion currently, assuming 35% oral penetration.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.